LATEST RESEARCH

Research

Independent analysis of SEC filings, private funds, RIAs, websites and regulatory records.

AGC Familiar I SEC Review: Zero Sales, Cross-Border Adviser Confusion and an Unidentified "Familiar" Investment
INDEPENDENT RESEARCH

AGC Familiar I SEC Review: Zero Sales, Cross-Border Adviser Confusion and an Unidentified "Familiar" Investment

AGC Familiar I SEC Review: The Regulatory Footprint Is Real, but the Investment Behind the Name Is Still Missing

AGC Familiar I, a Series of AGC Parallax Fund I LLC · CIK 0002158800Read article →
1812 Municipal Fund SEC Review: $0 Raised and Major Transparency Questions Around a New Municipal Hedge Fund
INDEPENDENT RESEARCH

1812 Municipal Fund SEC Review: $0 Raised and Major Transparency Questions Around a New Municipal Hedge Fund

1812 Municipal Fund SEC Review: The Name Suggests a Specialized Bond Strategy, but the Public Fund Infrastructure Is Almost Invisible

1812 Municipal Fund LP · CIK 0002158419Read article →
NU-0826 Fund I SEC Review: $184,400 Fully Sold, 26 Investors and the Hidden Asset Behind Schroeder Investments
INDEPENDENT RESEARCH

NU-0826 Fund I SEC Review: $184,400 Fully Sold, 26 Investors and the Hidden Asset Behind Schroeder Investments

NU-0826 Fund I, a series of Schroeder Investments, LP is a small but fully subscribed venture vehicle whose October 6, 2026 Form D reports exactly $184,400 sold to 26 investors. The offering began on October 2, only four days before the filing, carries a $1,000 reported minimum and relies on Rule 506(b) together with Section 3(c)(1). Those facts make NU-0826 materially different from the numerous $0-sold SPVs in this filing group: investors had already committed the entire stated offering when the initial notice was filed. The more difficult question is what those 26 investors actually purchased. The legal name contains an internal-looking "NU-0826" code, the Form D does not identify a portfolio company, and no current detailed ADV private-fund disclosure was found that independently reveals the underlying asset, adviser, custodian or valuation.

NU-0826 Fund I, a series of Schroeder Investments, LP · CIK 0002153569Read article →
IronArc Opportunities XXIX Review: $14.7M Raise and Late Form D
INDEPENDENT RESEARCH

IronArc Opportunities XXIX Review: $14.7M Raise and Late Form D

IronArc Opportunities XXIX, LP is a fully subscribed $14.69 million venture vehicle that looks straightforward in Form D but becomes considerably more interesting once IronArc's broader history is reconstructed. The October 2 filing reports 16 investors, a $100,000 minimum, no broker or sales-compensation recipient, zero sales commissions, zero finder's fees and zero offering proceeds allocated to related persons. The simple average subscription is approximately $918,000, although actual commitments can differ substantially, so this is clearly not a small-ticket syndicate despite the $100,000 formal minimum. Patrick Flynn signed the filing as principal of IronArc GP-A, LLC, and the current IronArc website describes a high-conviction strategy spanning Anthropic, CoreWeave, Anduril, Saronic, SpaceX, Groq, Replit, Scale AI, xAI, Shield AI, Glean and other AI and physical-infrastructure companies. What Form D does not identify is the most important investment fact: it gives no portfolio-company name for Opportunities XXIX. That opacity matters because the IronArc Opportunities numbering system is not itself a diversified-fund designation; independent SEC reporting has already demonstrated that at least one earlier numbered vehicle, IronArc Opportunities XXI, was a dedicated investment in Saronic Technologies Series D preferred stock. Investors should therefore treat XXIX as potentially concentrated transaction exposure until its private documents prove otherwise, rather than assuming the Roman numeral refers to a diversified twenty-ninth flagship fund.

IronArc Opportunities XXIX, LP · CIK 0002157452Read article →
1540 Ventures Fund I SEC Review: $50M Target, Zero Sales and a Valuation-Conflict Question
INDEPENDENT RESEARCH

1540 Ventures Fund I SEC Review: $50M Target, Zero Sales and a Valuation-Conflict Question

1540 Ventures Fund I SEC Review: A $50 Million Target Built on a Very Limited Public Fund Track Record

1540 Ventures Fund I, LP · CIK 0002158664Read article →
Impulse Space WT Review: Whittier Trust SPV and $5B Valuation Risk
INDEPENDENT RESEARCH

Impulse Space WT Review: Whittier Trust SPV and $5B Valuation Risk

Impulse Space (WT), LP should not be confused with Impulse Space, Inc.'s own $500 million Series D financing. The October 2 Form D belongs to a separate Delaware investment partnership headquartered for filing purposes at 100 W Liberty Street in Reno and reports $3.716 million sold to 22 investors, a $100,000 minimum, an indefinite offering and no sales commissions or finder's fees. The people behind the vehicle immediately explain the letters "WT": Whittier Investments GP, LLC is named as general partner, while David Dahl, Robert Renken and Liam McGuinness hold the same CEO, general-counsel and CFO roles publicly associated with Whittier Trust. The Reno telephone number and address also match Whittier Trust Company of Nevada's official Reno office, although the Form D uses Suite 800 while Whittier's current public office page lists Suite 890. Whittier Trust describes itself as a multi-family office serving wealthy families and openly markets access to private equity, venture capital and other private-market opportunities. This makes the vehicle's institutional identity unusually easy to establish: Impulse Space (WT) appears to be a Whittier-sponsored access vehicle rather than an SPV created by Impulse Space management itself. Investors therefore need to analyze two separate layers—the quality and price of Impulse Space equity, and the legal, fee and governance structure through which Whittier clients obtain that exposure.

Impulse Space (WT), LP · CIK 0002155678Read article →
WV-MT2 SEC Review: $2.15M Fully Sold but Wisdom Ventures Does Not Publicly Identify the MT2 Asset
INDEPENDENT RESEARCH

WV-MT2 SEC Review: $2.15M Fully Sold but Wisdom Ventures Does Not Publicly Identify the MT2 Asset

WV-MT2 SEC Review: Wisdom Ventures Is Easy to Verify, but the $2.15 Million Asset Behind "MT2" Is Not

WV-MT2 a Series of CGF2021 LLC · CIK 0002156334Read article →
WealthHaus Alpha Partners SEC Review: $0 Raised and a New Hedge Fund Outside the Firm's Public Wealth-Advisory Story
INDEPENDENT RESEARCH

WealthHaus Alpha Partners SEC Review: $0 Raised and a New Hedge Fund Outside the Firm's Public Wealth-Advisory Story

WealthHaus Alpha Partners SEC Review: The Advisors Are Verifiable, but the Hedge Fund Has Almost No Independent Track Record Yet

WealthHaus Alpha Partners, LP · CIK 0002158186Read article →
IHP Co-Invest IV-B Review: $3.16M Form D and Filing Delay
INDEPENDENT RESEARCH

IHP Co-Invest IV-B Review: $3.16M Form D and Filing Delay

IHP Co-Invest IV-B, LP is a small but institutionally connected medical-device private-equity vehicle managed within the InnovaHealth Partners organization. Its October 2, 2026 Form D reports $3.16 million sold to five investors, an indefinite offering, no sales commissions or finder's fees and no fixed minimum investment. The simple average commitment is approximately $632,000 per investor, although actual allocations may vary, and the fund relies on Section 3(c)(7), meaning the economic reality is much more exclusive than the $0 minimum field suggests. The strongest positive is that the adviser is unusually easy to verify: InnovaHealth Partners, LP is an SEC-registered investment adviser under CRD 297788 and SEC file 801-126204, effective since July 2022, and its August 2026 Form ADV explicitly includes IHP Co-Invest IV-B among the firm's private funds. InnovaHealth reported roughly $301 million of regulatory assets under management for its 2025 fiscal year, all associated with pooled investment vehicles, while the same ADV identifies a wider family of IHP Co-Invest I through VI vehicles. This makes IV-B very different from a standalone Form D whose management structure cannot be independently reconstructed.

IHP Co-Invest IV-B, LP · CIK 0002118201Read article →
Northstar VC Series 39 SEC Review: $0 Sold, 39-Series SPV Trail and the Missing Underlying Investment
INDEPENDENT RESEARCH

Northstar VC Series 39 SEC Review: $0 Sold, 39-Series SPV Trail and the Missing Underlying Investment

Northstar VC Series 39 looks like the thirty-ninth installment of an established venture-investment program, but investors should be careful not to confuse the maturity implied by the number with the status of this particular issuer. The October 6, 2026 Form D reports an indefinite Rule 506(b) offering, a $100,000 minimum, $0 sold, zero investors and "First Sale Yet to Occur." The filing therefore confirms that a new Northstar vehicle exists, but it does not establish that Series 39 has raised capital, purchased a portfolio-company security or even completed its first subscription. What makes the filing more interesting is the infrastructure behind it: Northstar Venture Capital has a substantial history of numbered Series issuers, an operating website with an identifiable investment team and portfolio, and at least one earlier series that can be independently traced into an actual portfolio-company securities document. The principal risk with Series 39 is consequently not whether Northstar exists, but that the public record gives investors almost no information about what this particular series is intended to own.

NORTHSTAR VC SERIES 39 A SERIES OF NORTHSTAR VENTURE CAPITAL LLC · CIK 0002158839Read article →
Warburg Pincus Global 15 Access Offshore SEC Review: $10.28M Raised but Investors Sit Behind a Goldman Access Layer
INDEPENDENT RESEARCH

Warburg Pincus Global 15 Access Offshore SEC Review: $10.28M Raised but Investors Sit Behind a Goldman Access Layer

Warburg Pincus Global 15 Access Offshore SEC Review: The Brand Is Institutional, but the Investor Is Still One Layer Removed

Warburg Pincus Global 15 Access Offshore SCSp · CIK 0002122218Read article →
GSBackers AALO Fund III Review: $3.1M Form D and Aalo Atomics Risks
INDEPENDENT RESEARCH

GSBackers AALO Fund III Review: $3.1M Form D and Aalo Atomics Risks

GSBackers AALO Fund III is not an anonymous SPV whose underlying company has to be guessed from initials. The sponsor itself publicly lists Aalo among its energy investments, and this is now the third SEC vehicle carrying the Aalo name. Fund I filed in August 2025 with $2.2125 million fully sold, Fund II followed in February 2026 with $5.0125 million sold to 84 investors, and Fund III reported another $3.065 million fully subscribed by 62 investors only three days after its September 29, 2026 first sale. The latest Form D reports no sales commission, no finder's fee and only $22 allocated to organizational and operating expenses, while GSBackers LLC is directly named as an executive officer. This repeated vehicle history matters because it shows continued sponsor demand for Aalo exposure rather than a one-time opportunistic syndicate. GSBackers itself says it manages a $250 million-plus venture portfolio for more than 2,000 Stanford Graduate School of Business alumni and typically makes $1 million to $10 million-plus investments, with Aalo listed alongside other frontier-technology companies. The positive signal is therefore strong: the sponsor is identifiable, Aalo is an acknowledged portfolio company, and three separate private vehicles have now been built around the investment. The corresponding risk is equally clear: Fund III appears designed around concentrated exposure to one advanced-nuclear company, so the number of LPs does not create portfolio diversification. Sixty-two investors can still all lose money together if Aalo fails to convert technical milestones into economical commercial reactors.

GSBackers AALO Fund III a Series of CGF2021 LLC · CIK 0002151988Read article →